A randomized controlled trial conducted at the University of Maryland School of Medicine has found that a five-minute session of proximal intercessory prayer (PIP) — in-person prayer offered by a trained volunteer — significantly reduced pain and anxiety in primary care patients compared to a music control group. The findings, published in the May/June 2026 issue of Annals of Family Medicine, suggest that proximal intercessory prayer may offer a practical, non-pharmacologic complement to conventional care, particularly for underserved populations.

The newly integrated University of Texas at San Antonio and its academic health center, UT Health San Antonio, recently received over $2.7 million from the Cancer Prevention and Research Institute of Texas (CPRIT) to help develop the next generation of cancer researchers and focus on Ewing sarcoma, AI in oncology and the obesity-endometrial cancer risk.

Dr. Jason Chiang and Dr. Kyung Sung of the department of radiological sciences at the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center have received a $3.2 million, five-year grant from the National Cancer Institute to develop an artificial intelligence (AI)-enhanced imaging platform designed to improve yttrium-90 (Y90) radioembolization planning for patients with liver cancer.

Dr. Mina Sedrak, director of the UCLA Center for Cancer and Aging and director of Cancer Control and Survivorship Research at the UCLA Health Jonsson Comprehensive Cancer Center, has been selected to serve as co-chair of the Cancer in the Older Adult Committee for The Alliance for Clinical Trials in Oncology.

Telemedicine, continuous monitoring, and remote procedures are becoming increasingly important in medicine. For these to operate seamlessly in everyday clinical practice, data must be transmitted quickly, reliably, and without interruption. Researchers at the Technical University of Munich (TUM) and TUM University Hospital have investigated how future 6G networks can manage computing power and data transmission in such a way that up to 40 percent more applications can be run simultaneously.

About The Study: In this cohort study of patients with early breast cancer, prediagnostic statin use was not associated with higher survival; however, postdiagnostic statin use was associated with lower all-cause and breast cancer–specific mortality among patients with hormone receptor–positive intrinsic subtypes. These findings suggest that statin therapy may improve survival of patients with early hormone receptor–positive subtypes.